Ning Dong Selected Research

ethyl pyruvate

7/2010	Association between high-mobility group box-1 protein release and immune function of dendritic cells in thermal injury.
3/2009	The effect of high-mobility group box 1 protein on activity of regulatory T cells after thermal injury in rats.
10/2008	Relationship between high-mobility group box 1 protein release and T-cell suppression in rats after thermal injury.
3/2006	[Effect of treatment with ethyl pyruvate on multiple organ dysfunction and mortality following delayed resuscitation after burn injury in rat].
7/2005	[Effects of ethyl pyruvate on splenocyte proliferation and apoptosis in burn rats with delayed resuscitation].
1/2005	[Effects of ethyl pyruvate on cell-mediated immune function in rats with delayed resuscitation after burn injury].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ning Dong Research Topics

Disease

49	Sepsis (Septicemia) 01/2024 - 04/2002
28	Burns 01/2019 - 01/2003
19	Inflammation (Inflammations) 01/2024 - 07/2006
18	Infections 01/2024 - 11/2003
16	Neoplasms (Cancer) 12/2023 - 11/2017
8	Poisoning 04/2023 - 05/2013
7	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2024 - 11/2012
6	Multiple Organ Failure (MODS) 09/2014 - 04/2003
5	Cataract (Cataracts) 01/2023 - 01/2013
4	Hyperglycemia 03/2024 - 02/2018
4	Macular Edema 04/2018 - 01/2013
4	Carbon Monoxide Poisoning (Poisoning, Carbon Monoxide) 04/2016 - 05/2013
3	Wounds and Injuries (Trauma) 03/2024 - 01/2019
3	Breast Neoplasms (Breast Cancer) 01/2023 - 11/2017
3	Heart Failure 01/2022 - 01/2013
3	Organophosphate Poisoning 01/2021 - 01/2020
3	Osteoarthritis 01/2020 - 01/2019
3	Osteonecrosis (Kienbock's Disease) 01/2020 - 12/2016
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2020 - 01/2018
2	Obesity 02/2024 - 01/2020
2	Osteoporosis 02/2024 - 01/2023
2	Liver Neoplasms (Liver Cancer) 02/2024 - 01/2023
2	Critical Illness (Critically Ill) 01/2024 - 01/2011
2	Retinal Detachment (Retinal Detachments) 11/2023 - 01/2023
2	Diarrhea 06/2023 - 01/2023
2	Hemorrhage 01/2023 - 09/2014
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 01/2023
2	Lung Neoplasms (Lung Cancer) 06/2021 - 11/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2021 - 05/2021
2	Ischemic Stroke 01/2021 - 01/2014
2	Pneumonia (Pneumonitis) 01/2021 - 01/2018
2	Heart Arrest (Cardiac Arrest) 01/2021 - 04/2016
2	Hypotension (Low Blood Pressure) 01/2021 - 01/2021
2	Salmonella Infections (Salmonellosis) 01/2019 - 01/2018
2	Diabetes Mellitus 12/2018 - 11/2012
2	Type 2 Diabetes Mellitus (MODY) 04/2018 - 01/2013
2	Brain Injuries (Brain Injury) 11/2017 - 04/2016

Drug/Important Bio-Agent (IBA)

21	HMGB1 Protein (HMG1)IBA 01/2021 - 03/2003
20	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2003
17	CytokinesIBA 01/2023 - 11/2003
14	salicylhydroxamic acid (SHAM)IBA 10/2021 - 04/2003
10	Carbapenems (Carbapenem Antibiotics)IBA 12/2023 - 01/2018
8	Retinaldehyde (Retinal)IBA 03/2024 - 11/2012
8	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2014
8	Messenger RNA (mRNA)IBA 01/2019 - 04/2002
7	Anti-Bacterial Agents (Antibiotics)IBA 12/2023 - 01/2018
6	Interleukin-2 (IL2)IBA 01/2011 - 01/2005
6	ethyl pyruvateIBA 07/2010 - 01/2005
5	LipopolysaccharidesIBA 01/2023 - 04/2010
5	Colistin (Coly-Mycin)FDA Link 06/2022 - 07/2018
5	Sirolimus (Rapamycin)FDA Link 01/2017 - 03/2003
5	Carbon MonoxideIBA 04/2016 - 05/2013
5	GelsolinIBA 02/2016 - 01/2011
4	XuebijingIBA 01/2024 - 01/2006
4	Tigecycline (Tygacil)FDA Link 06/2022 - 07/2018
4	MicroRNAs (MicroRNA)IBA 01/2021 - 11/2014
4	EndotoxinsIBA 01/2018 - 04/2002
4	alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA 03/2009 - 03/2003
4	Janus KinasesIBA 03/2009 - 03/2003
3	VaccinesIBA 12/2023 - 01/2022
3	2019-nCoV Vaccine mRNA-1273IBA 12/2023 - 01/2022
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2021 - 04/2004
3	Indicators and Reagents (Reagents)IBA 06/2021 - 03/2018
3	Advanced Oxidation Protein Products (AOPP)IBA 01/2021 - 01/2020
3	InterleukinsIBA 10/2020 - 01/2020
3	AdipokinesIBA 01/2020 - 01/2018
3	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2013
3	HomocysteineIBA 04/2018 - 11/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 03/2009
3	HLA-DR Antigens (HLA-DR)IBA 09/2008 - 01/2003
2	COVID-19 VaccinesIBA 12/2023 - 01/2022
2	AntibodiesIBA 12/2023 - 12/2015
2	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2022
2	Small Cytoplasmic RNAIBA 01/2023 - 01/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2022 - 01/2021
2	Cholinesterases (Cholinesterase)IBA 01/2021 - 01/2021
2	Neuroprotective AgentsIBA 01/2021 - 05/2013
2	LeptinIBA 01/2020 - 01/2018
2	Advanced Glycation End ProductsIBA 01/2020 - 03/2009
2	S100A12 ProteinIBA 11/2019 - 07/2015
2	Exenatide (Byetta)FDA Link 01/2019 - 02/2018
2	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2019 - 01/2018
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2019 - 02/2018
2	Streptozocin (Streptozotocin)FDA Link 12/2018 - 11/2012
2	NucleotidesIBA 10/2018 - 11/2017
2	Adenosine Triphosphate (ATP)IBA 10/2018 - 11/2017
2	Vasopressins (Vasopressin)IBA 04/2016 - 09/2014

Therapy/Procedure

15	Ligation 01/2024 - 03/2003
14	Punctures 01/2024 - 03/2003
10	Therapeutics 09/2023 - 01/2003
5	Resuscitation 01/2022 - 01/2005
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2024 - 08/2007
3	Lasers (Laser) 01/2023 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2021
2	Immunotherapy 06/2021 - 05/2021
2	Mechanical Ventilators (Ventilator) 01/2021 - 02/2012
2	Arthroplasty 01/2020 - 02/2017
2	Artificial Respiration (Mechanical Ventilation) 01/2018 - 02/2012
2	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2017 - 12/2016